Structural aberrations are associated with poor survival in patients with clonal cytopenia of undetermined significance

Stine U Mikkelsen; Setareh Safavi; Konstantinos Dimopoulos; Colm J O'Rourke; Mette K Andersen; Mette S Holm; Claus W Marcher; Jesper B Andersen; Jakob W Hansen; Kirsten Grønbæk

doi:10.3324/haematol.2020.263319

Structural aberrations are associated with poor survival in patients with clonal cytopenia of undetermined significance

Haematologica. 2021 Jun 1;106(6):1762-1766. doi: 10.3324/haematol.2020.263319.

Authors

Affiliations

¹ Department of Hematology, Rigshospitalet, Copenhagen, Denmark; Biotech Research and Innovation Centre (BRIC), Department of Health and Medical Sciences, University of Copenhagen, Copenhagen.
² Department of Clinical Genetics, Rigshospitalet, Copenhagen.
³ Department of Clinical Biochemistry, Rigshospitalet, Copenhagen.
⁴ Biotech Research and Innovation Centre (BRIC), Department of Health and Medical Sciences, University of Copenhagen, Copenhagen.
⁵ Department of Hematology, Aarhus University Hospital, Aarhus.
⁶ Department of Hematology, Odense University Hospital, Odense.
⁷ Department of Hematology, Rigshospitalet, Copenhagen, Denmark; Biotech Research and Innovation Centre (BRIC), Department of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; DanStem, University of Copenhagen, Copenhagen.
⁸ Department of Hematology, Rigshospitalet, Copenhagen, Denmark; Biotech Research and Innovation Centre (BRIC), Department of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; DanStem, University of Copenhagen, Copenhagen. Kirsten.Groenbaek@regionh.dk.

Abstract

Not available.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Anemia*
Chromosome Aberrations
Clonal Hematopoiesis
Humans
Myelodysplastic Syndromes* / diagnosis
Myelodysplastic Syndromes* / genetics
Thrombocytopenia*

Grants and funding

Funding: the project is part of the Danish Research Center for Precision Medicine in Blood Cancers funded by the Danish Cancer Society (grant no. R223-A13071) and Greater Copenhagen Health Science Partners. The Novo Nordisk Foundation Center for Stem Cell Biology (DanStem) is supported by a Novo Nordisk Foundation grant (grant no. NNF17CC0027852).